Significance of Clinical Lipidomics Xiangdong Wang MD, PhD, Distinguished Professor of Medicine, Director of Shanghai Institute of Clinical Bioinformatics, Executive Director of Clinical Science Institute of Fudan University Zhongshan Hospital, Deputy Director of Shanghai Respiratory Research Institute, Shanghai, China
Membrane lipidomics and personalised health Carla Ferreri, ISOF, Consiglio Nazionale delle Ricerche, Bologna, Italy
Mitochondrial Lipid Metabolism and Diseases Linlin Zhang, Clinical Science Institute of Fudan University Zhongshan Hospital, Shanghai, China; Aurelio Reyes, MRC Mitochondrial Biology Unit (MRC MBU), University of Cambridge, UK
Breast cancer and lipid metabolism: Apoptosis and Cancer Therapy Chunfa, Huang, Division of Hematology/Oncology, Department of Internal Medicine, School of Medicine and Cancer Center, Saint Louis University, USA;
Lipidomics in gastric cancer Hui Zhang, Henan Province People Hospital, Zhangzhou, China
Changes of circulating lipidomes in lung cancer Jiapei Lv, Clinical Science Institute of Fudan University Zhongshan Hospital, Shanghai, China; Madhav Bhatia, Department of Pathology, University of Otago, Christchurch, New Zealand.
Lipidomics in Liver Cancer Huoli Shen, PhD, Associate Professor of Metabolomics, Fudan University Institute of Biomedicine, Shanghai, China;
Lipidomics in Neurodegenerative Diseases Dongming Cai, Department of Neurology, Alzheimer Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA;
Clinical lipidomics in cystic fibrosis Mario Ollero, Institut Mondor de Recherche Biomédicale, INSERM, Hôpital Henri Mondor, France;
Clinical sphingolipidomics Alfred Merrill, Schools of Chemistry and Biochemistry, Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, USA;
Differential Sphingolipid and Phospholipid Profiles in liver diseases Suzanne de la Monte, Liver Research Center, Division of Gastroenterology and Department of Medicine, Brown University, Providence, RI, USA
Dendritic Cell Metabolism and Lipidomices Duojiao Wu, MD, PhD, Associate Professor of Medicine, Office Director of Clinical Science Institute of Fudan University Zhongshan Hospital, Assistant Director of Shanghai Institute of Clinical Bioinformatics, Shanghai, China;
The emerging roles of extracellular vesicle – shuttling molecules as biomarkers Yang Jin, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Boston University, USA
Lipidomics in alcohol use disorder Seth Devanshi, Discipline of Clinical Medicine & Addiction Medicine, Faculty of Medicine, University of Sydney, Australia;
Lipid-mediated Protein-protein Interactions Modulate Respiration-driven ATP Synthesis Peter Brzezinski, Department of Biochemistry and Biophysics, Arrhenius Laboratories for Natural Sciences, Stockholm University, Sweden
Dr. Xiangdong Wang is Distinguished Professor at Zhongshan Hospital Fudan University.
This volume covers the emerging area of science, Clinical Lipidomics, which is theapplication of lipidology to the understanding of physiological and pathophysiological changes of lipidomes, with a special focus on lipidomic profiles in human diseases.
Lipidomics is widely used to map lipid molecular species in a biological system. Clinical lipidomic analysis has demonstrated the comprehensive characterization of molecular lipids in various severities, durations, and therapies as a critical tool in identification and validation of disease-specific biomarkers.
This volume on Clinical Lipidomics will add to the literature and help advance the knowledge of the pathogenesis, diagnosis, prevention and treatment of diseases.